Sponsor

Click Therapeutics, Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Click Therapeutics, Inc. appears in 10 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials10
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

10 shown
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.NCT06486948 · lead sponsor · 2024-05-06
COMPLETED
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung CancerNCT06136923 · lead sponsor · 2023-10-19
COMPLETED
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With SchizophreniaNCT06136936 · lead sponsor · 2023-09-20
COMPLETED
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of SchizophreniaNCT06067984 · lead sponsor · 2023-09-12
COMPLETED
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaNCT05838625 · lead sponsor · 2023-03-31
COMPLETED
Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component TrainingNCT05573685 · lead sponsor · 2022-10-10
COMPLETED
7-week Study With CT-155 in People With SchizophreniaNCT05486312 · lead sponsor · 2022-07-05
COMPLETED
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood SymptomsNCT05438147 · lead sponsor · 2022-05-13
COMPLETED
Exploratory Study of a Digital Therapeutics in People With SchizophreniaNCT05438160 · lead sponsor · 2022-03-31
COMPLETED
Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive DisorderNCT04770285 · collaborator · 2021-02-25
COMPLETED

Drugs studied in this sponsor's trials

0 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Click Therapeutics, Inc. as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

No mapped drug interventions are published for this sponsor's trials. This does not mean the studies contain no drug interventions: some registry names have not been mapped to RxNorm.

Sponsor roles

lead sponsor9
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.